MISSION STATEMENT

To supply the global market with a simple solution to identify mRNA and other molecules in vaccines to help keep us safe and prevent future out-breaks.

THE SITUATION

With present day technology advancement, pulse oximeters worn over the fingertip can easily measure an individual’s blood oxygen level. The Pandemic and its resulting shutdowns has led to the question of utilizing such testing procedure technology in medical diagnostics. 

PRODUCT DESCRIPTION

Ahadu is an AI designed to identify mRNA and other molecules in vaccines to help keep us safe and prevent future out-breaks. This non-invasive diagnostic technology absorbs particles such as sweat, skin cells, body temperature from the surface of the body and moisture of skin. Once the temperature sensing screen identifies the particles, the cell identification technology analyzes it and a descriptive report is produced. The report can be emailed to the user or printed out for a physical copy. 

OBJECTIVES

The developers of Ahadu are offering to license the manufacturing and distribution rights to qualified organizations. These organizations should be capable of producing the product and/or accessing the appropriate markets with the product.

INTELLECTUAL PROPERTY PROTECTION

Ahadu is the subject of Patent Pending in United States. Other territories are being considered on an as needed basis.

CONTACT INFORMATION

Innovative Licensing & Promotion, Inc. is the exclusive licensing agent representing the developers of Ahadu.

Innovative Licensing & Promotion, Inc.

Attn: Ron Wiseman

VP, Licensing Operations

100 King Street West

Toronto, ON M5X 1C7

Phone: 647-360-7700

Email: licensing@2innovative.net

Website: www.2innovative.net